Craft
Remegen

Remegen

Total Funding

$100 M

Remegen Summary

Company summary

Overview
Remegen is a company that develops biopharmaceutical products. The company focuses on research and development, manufacturing and commercialization of biologics, notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs), enabling patients and clinicians with pharmaceutical products for the treatment of cancer, autoimmune and eye-related diseases.
Type
Private
Status
Active
Founded
2008
HQ
Yantai, CN | view all locations
Website
https://remegen.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Jianmin Fang

    Jianmin Fang, Founder, CEO & CSO

    LocationsView all

    1 location detected

    • Yantai, Shandong HQ

      China

    Footer menu